Physiomics to Present at BioTrinity 2018

Physiomics plc (AIM: PYC), a provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry, is pleased to announce that it will attend BioTrinity 2018.  BioTrinity is one of Europe’s leading biopartnering and investment conferences, to be held on 23-25 April at the Novotel London West.

Click here to read more.